Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,259 public trials 1,188 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Enrolling by Invitation

Molecular Analysis of Thoracic Malignancies

NCT01385722

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Enrolling by Invitation

Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional Methods

NCT07301983

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Pisa Pisa, Italy

View Trial Details

Enrolling by Invitation

ROSE for Improved Molecular Marker Testing Via EBUS

NCT04945317

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Northwestern Medicine Chicago, Illinois, United States

Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

Johns Hopkins Hospital Baltimore, Maryland, United States

The Medical University of South Carolina (MUSC) Charleston, South Carolina, United States

View Trial Details

Enrolling by Invitation

Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer

NCT07285434

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Biogenea Pharmaceuticals Ltd Thessaloniki, Macedonia, Greece

View Trial Details

Enrolling by Invitation

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

NCT06603987

Conditions: Adenoma, Breast Diseases, Breast Neoplasms, +40 more
Locations: ORIX Kouraibashi Bldg. 8F 3-2-7 Kouraibashi Chuo-ku Osaka, Japan

View Trial Details

Enrolling by Invitation

Evaluating the Feasibility and Preliminary Effects of BE+

NCT07214441

Conditions: Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations: University of South Carolina Columbia, South Carolina, United States

View Trial Details

Enrolling by Invitation

Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

NCT06997458

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations: Centre for Genomics and Oncological Research - Pfizer - University of Granada - Andalusian Regional Government (GENyO) Granada, Andalusia, Spain

View Trial Details

Enrolling by Invitation

Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)

NCT06419179

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: University Hospital Cologne Cologne, North Rhine-Westphalia, Germany

View Trial Details

Enrolling by Invitation

Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer

NCT06962449

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by Invitation

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

NCT06690216

Conditions: Astrocytoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions